# Boston Scientific Corporation (BSX) — Q4-2017 Earnings Results

**Report date:** 2018-02-01 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2017

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Down 1.18%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.34 | N/A | -3.11% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautious optimism about future opportunities despite current market challenges. They emphasized their commitment to innovation and growth.

**Key quotes:**

> Management highlighted ongoing investments in innovation.

> They acknowledged challenges in the market but expressed confidence in long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report indicates a slight miss on EPS, which contributed to a 1.18% decline in stock price. The company did not provide revenue figures or future guidance, leaving investors with limited insights into its financial outlook. Management's cautious tone suggests they are aware of market challenges but remain focused on long-term growth strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2017_